When Paulette Quick was diagnosed with age-related macular degeneration (AMD), it came as a complete shock. As a former CPR instructor and amateur radio operator, she hadn’t noticed any symptoms. It was only after a …
Research News
UW-Madison Scientist Awarded Prestigious Fellowship to Explore New Therapies in the Fight Against Blindness
A University of Wisconsin vision scientist has been awarded a prestigious global fellowship to investigate new therapies for rare inherited blindness. Bikash Pattnaik, PhD, MPHIL, has been named a 2025-2028 VAIshwik BHArtiya Vaigyanik (VAIBHAV) fellow …
UW Vision Researchers Explore Stem Cell Replacement Therapy Using Lab-Grown Photoreceptors as Promising Strategy to Combat Retinal Disease
UW vision researchers explore stem cell replacement therapy using lab-grown photoreceptors as a promising strategy to combat retinal disease.
UW-Madison Vision Researchers Explore Artificial Intelligence Technology to Assist Individuals with Low Vision
A recent R01 award from the National Eye Institute (NEI) and National Institutes of Health (NIH) enables a collaborative, multidisciplinary team of researchers, low vision specialists, engineers, and computer scientists from the University of Wisconsin—Madison …
Whitney A. Stevens-Sostre, PhD, Receives Prestigious Hanna Gray Fellowship
A post-doctoral researcher in the University of Wisconsin-Madison Department of Ophthalmology and Visual Sciences has received a prestigious national award in recognition of her transformational scientific research in the visual sciences. Whitney A. Stevens-Sostre, PhD, …
University of Wisconsin Vision Scientists Participate in Groundbreaking Efforts to Develop Treatment to Cure Blindness
Two vision researchers at the University of Wisconsin-Madison are involved in groundbreaking research aimed at curing blindness through human eye transplantation. To date, there has never been a successful whole human eye transplant for the restoration of vision. However, research teams across the country, including at the University of Wisconsin—Madison, are hopeful these efforts will pave the way for this procedure.
Taking Steps to Restore Vision: Launching a Stem Cell Clinical Trial for Retinitis Pigmentosa
The FDA has approved a groundbreaking stem cell clinical trial for retinitis pigmentosa. The trial is the next step in the work spearheaded by world-renowned vision researcher David Gamm, MD, PhD.
Equal Vision: Employing Artificial Intelligence to Reduce Disparities in the Diagnosis and Treatment of Vision Loss
Roomasa Channa, MD is utilizing artificial intelligence technology to improve screening and detection of diabetic eye disease, the leading cause of vision loss among working aged adults in the U.S.
UW—Madison Scientists Seek to Revolutionize Eye Care with Adaptive Optics Technology
Vision scientists at the University of Wisconsin—Madison are pioneering a revolutionary approach to eye care by adapting a cutting-edge imaging technique from astronomy for use in ophthalmology.